posted on 2008-06-26, 00:00authored byDana Ferraris, Bridget Duvall, Yao-Sen Ko, Ajit G. Thomas, Camilo Rojas, Pavel Majer, Kenji Hashimoto, Takashi Tsukamoto
d-Amino acid oxidase (DAAO) catalyzes the oxidation of d-amino acids including d-serine, a full agonist at the glycine site of the NMDA receptor. A series of benzo[d]isoxazol-3-ol derivatives were synthesized and evaluated as DAAO inhibitors. Among them, 5-chloro-benzo[d]isoxazol-3-ol (CBIO) potently inhibited DAAO with an IC50 in the submicromolar range. Oral administration of CBIO in conjunction with d-serine enhanced the plasma and brain levels of d-serine in rats compared to the oral administration of d-serine alone.